Advertisement

cbdMD, Inc. YCBD

Set alert

Price alert · YCBD

All alert types
0.38 USD -0.01 -1.34%

At close · Oct 30

0.38 0.00 -0.89%

After hours · Oct 30, 5:05 PM ET

Bid
0.35 × 5,100
Ask
0.40 × 200
0.37 Day range 0.3925
0.348 52-week range 2.27
YTD
-71.65%
1 year
-56.51%
Open
0.3763
Prev close
0.3879
Mkt cap
4.29M
Vol
48.34K
Avg vol
392.15K
EPS
0.23
P/E
1.66
Div yield
0.00%
More statistics
Low
0.37
High
0.3925
Forward P/E
-0.38
Beta
1.99
Short ratio
1.14
Inst. own
3.33%
Dividend
0.00
Ex-div date
Earnings
Feb 11, 2025
50-d avg
0.46466
200-d avg
0.61418
1y target
2.00

6M chart

Chart tools
Interval

Signals (19)
NameDateAgo
MACD: Buy SignalOct 21, 20261 week ago
RSI: OversoldOct 12, 20262 weeks ago
MACD: Sell SignalOct 5, 20263 weeks ago
MACD: Buy SignalSep 22, 20261 month ago
MACD: Sell SignalSep 21, 20261 month ago
MACD: Buy SignalAug 25, 20262 months ago
MACD: Sell SignalAug 18, 20262 months ago
MACD: Buy SignalAug 4, 20262 months ago
RSI: OversoldJul 24, 20263 months ago
MACD: Sell SignalJul 15, 20263 months ago
SMA: BearishJul 13, 20263 months ago
SMA: BearishJul 13, 20263 months ago
SMA: BullishJul 9, 20263 months ago
SMA: BullishJul 9, 20263 months ago
MACD: Buy SignalJun 25, 20264 months ago
SMA: BearishMay 29, 20265 months ago
SMA: BullishMay 28, 20265 months ago
SMA: BearishMay 15, 20265 months ago
MACD: Sell SignalMay 5, 20266 months ago

Key statistics

Market cap
1.53M
Enterprise value
3.22M
Trailing P/E
0.00
Forward P/E
-0.38
PEG ratio
0.00
Price / sales
0.07
Price / book
0.43
EPS (TTM)
-1.79
Beta
1.99
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-94.12%
Revenue (TTM)
20.64M
Revenue growth
-15.50%
Free cash flow
4.69M
Total cash
2.40M
Total debt
4.11M
Return on equity
-135.07%
Shares outstanding
4.47M
Short % of float
4.74%
50-day average
0.46466
200-day average
0.61418

Analyst view

Consensus: none

Price target (mean) 2.00

Next earnings

Feb 11, 2025

Expected Feb 11, 2025. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
YCBD Revenue — quarterly 5.55M
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026
YCBD Net income — quarterly -1.13M
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026
YCBD EPS — quarterly -0.11
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026

Earnings

YCBD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 11, 2025Dec 1, 20240.00———
Dec 17, 2024Sep 1, 20240.00———
Aug 14, 2024Jun 1, 20240.00-0.15——
May 15, 2024Mar 1, 20240.00-1.35——
Feb 13, 2024Dec 1, 20230.00-0.67——
Dec 22, 2023Sep 1, 20230.00-9.06——

Upgrades / downgrades

YCBD analyst upgrades and downgrades
DateFirmActionFromTo
Oct 5, 2023Maxim Groupinit—Buy

About cbdMD, Inc.

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Website
cbdmd.com

News

Your note

Sign in to keep a note on YCBD — it syncs with the Stock Master app.

Insider holders

YCBD insider holders
InsiderRelationLatest transactionDateShares held
COFFMAN RAYMOND SCOTTBeneficial Owner of more than 10% of a Class of SecurityStock Award(Grant)Jan 10, 20240
KENNEDY THOMAS RONANChief Executive OfficerPurchaseMay 2, 20236,462
RAINES WILLIAM F IIIDirectorStock Award(Grant)Aug 22, 202484,256
SELLERS BAKARI TDirectorStock Award(Grant)Mar 27, 20249,438
STEPHEN SCOTT GDirectorStock Award(Grant)Mar 27, 202410,138
SWIFT SIBYL NICHOLEDirectorStock Award(Grant)Mar 27, 20248,008

Institution ownership

YCBD institution ownership
Holder% heldSharesValueReported
Connective Capital Management LLC1.61%89,21530.53KSep 29, 2024
Two Sigma Securities, LLC0.40%22,0667.55KSep 29, 2024
Vanguard Group Inc0.24%13,0424.46KSep 29, 2024
Geode Capital Management, LLC0.20%11,1953.83KSep 29, 2024
Blackrock Inc.0.16%8,9053.05KSep 29, 2024
UBS Group AG0.06%3,1761.09KSep 29, 2024

Fund ownership

YCBD fund ownership
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund0.24%13,0424.46KSep 29, 2024
Fidelity Extended Market Index Fund0.16%8,9923.08KOct 30, 2024
Fidelity Total Market Index Fund0.02%1,124384Oct 30, 2024
Fidelity Series Total Market Index Fund0.02%1,079369Oct 30, 2024
Advertisement